Improving treatment strategies for opioid addiction
Official title: MOMS STUDY IMPLEMENTATION (CTN-0080). DSC6. 08/15/2023 - 04/30/2026. N01DA-22-2253. TASK ORDER 75N95023F00006 (TO10).
Funded at The Emmes Company, LLC · NIH-10939540 · Data updated 2026-11-12
This study is looking for ways to help people who are dealing with opioid misuse and addiction, and by joining in, you can help create better treatment options that could really make a difference in your recovery journey.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | August 15, 2023 |
| Project end | April 30, 2026 |
| Funding year | 2023 |
| Award (this year) | $500,879 |
| NIH project number | 75N95022D00017-0-759502300006-1 |
| Project ID | NIH-10939540 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are currently experiencing opioid misuse or addiction.
✕Less likely to help
Patients who are not struggling with opioid misuse or addiction may not receive any benefit from this research.
What this research studies
This research focuses on developing effective treatment strategies for individuals struggling with opioid misuse and addiction. It is part of the NIH's HEAL initiative, which aims to address the opioid crisis by finding rapid and sustainable solutions. The project will involve collaboration with various stakeholders to implement and evaluate these strategies in real-world settings, ensuring that they are practical and beneficial for patients. By participating, patients may contribute to the development of new approaches that could enhance their treatment options.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and support for individuals affected by opioid addiction.
How similar studies have gone: Previous initiatives under the HEAL program have shown promise in developing effective interventions for opioid addiction, indicating a potential for success with this approach.
Where this research is happening
-
The Emmes Company, LLC
Rockville, United States Active
Researchers
- Principal investigator: Mccormack, Jennifer — The Emmes Company, LLC
- Study coordinator: Mccormack, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.